Synonyms: FHD286
Compound class:
Synthetic organic
Comment: FHD-286 is a first-in-class oral allosteric BAF complex inhibitor. It targets the SMARCA4 (BRG1) subunit of the complex. FHD-286 was developed by Foghorn Therapeutics, and its chemical structure was disclosed at the AACR spring meeting in 2022.
|
|